Vital Therapies Company Profile (NASDAQ:VTL)

About Vital Therapies (NASDAQ:VTL)

Vital Therapies logoVital Therapies, Inc. is a biotherapeutic company. The Company is focused on developing a human hepatic cell-based treatment targeting acute forms of liver failure. Its product candidate, the ELAD System, is an extracorporeal human allogeneic cellular liver therapy designed to allow the patient's liver to regenerate to a healthy state, or to stabilize the patient until transplant. The ELAD System is a liver support system containing immortal human liver-derived cells, or VTL C3A cells. The Company initiated a Phase III clinical trial in severe acute alcoholic hepatitis (sAAH), referred to as VTL-308. Its VTL-308 is a randomized, open-label, multicenter, controlled, pivotal study, designed to evaluate the ELAD System in subjects with sAAH. It is based on pre-specified and post-hoc analyses of its VTI-208 phase III clinical trial in alcohol-induced liver decompensation (AILD). The Company's ELAD System consists of approximately four disposable ELAD C3A cell cartridges.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:VTL
  • CUSIP: N/A
  • Web: vitaltherapies.com
Capitalization:
  • Market Cap: $111.85 million
  • Outstanding Shares: 42,207,000
Average Prices:
  • 50 Day Moving Avg: $2.94
  • 200 Day Moving Avg: $3.84
  • 52 Week Range: $2.25 - $6.68
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.02
  • P/E Growth: -0.10
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: $2.00 per share
  • Price / Book: 1.33
Profitability:
  • EBIDTA: ($42,650,000.00)
  • Return on Equity: -61.78%
  • Return on Assets: -57.48%
Debt:
  • Current Ratio: 13.69%
  • Quick Ratio: 13.69%
Misc:
  • Average Volume: 206,373 shs.
  • Beta: 5.13
  • Short Ratio: 5.44
 
Frequently Asked Questions for Vital Therapies (NASDAQ:VTL)

What is Vital Therapies' stock symbol?

Vital Therapies trades on the NASDAQ under the ticker symbol "VTL."

How were Vital Therapies' earnings last quarter?

Vital Therapies, Inc. (NASDAQ:VTL) announced its quarterly earnings results on Tuesday, May, 9th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.37) by $0.02. During the same period in the prior year, the company posted ($0.31) EPS. View Vital Therapies' Earnings History.

When will Vital Therapies make its next earnings announcement?

Vital Therapies is scheduled to release their next quarterly earnings announcement on Monday, July, 31st 2017. View Earnings Estimates for Vital Therapies.

Where is Vital Therapies' stock going? Where will Vital Therapies' stock price be in 2017?

3 analysts have issued twelve-month target prices for Vital Therapies' stock. Their predictions range from $6.00 to $10.00. On average, they expect Vital Therapies' stock price to reach $8.00 in the next year. View Analyst Ratings for Vital Therapies.

Who are some of Vital Therapies' key competitors?

Who are Vital Therapies' key executives?

Vital Therapies' management team includes the folowing people:

  • Terence E. Winters Ph.D., Co-Chairman of the Board, Chief Executive Officer
  • Muneer A. Satter J.D., Co-Chairman of the Board, Lead Director
  • Michael V. Swanson M.B.A., Chief Financial Officer
  • Robert A. Ashley, Executive Vice President, Chief Technical Officer
  • Duane Nash M.D., Executive Vice President, Chief Business Officer
  • Aron P. Stern M.B.A., Chief Administrative Officer
  • Andrew Henry, Vice President - Clinical Operations
  • Andrea Loewen-Rodriguez, Vice President - Regulatory Affairs and Quality Assurance
  • Richard Murawski, Vice President - Manufacturing
  • John M. Dunn, General Counsel, Secretary

How do I buy Vital Therapies stock?

Shares of Vital Therapies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vital Therapies' stock price today?

One share of Vital Therapies stock can currently be purchased for approximately $2.65.


MarketBeat Community Rating for Vital Therapies (NASDAQ VTL)
Community Ranking:  2.6 out of 5 ( )
Outperform Votes:  96 (Vote Outperform)
Underperform Votes:  89 (Vote Underperform)
Total Votes:  185
MarketBeat's community ratings are surveys of what our community members think about Vital Therapies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Vital Therapies (NASDAQ:VTL) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $8.00 (201.89% upside)

Analysts' Ratings History for Vital Therapies (NASDAQ:VTL)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/18/2017Raymond James Financial, Inc.Initiated CoverageOutperform -> Outperform$6.00HighView Rating Details
3/10/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
1/2/2017Canaccord GenuitySet Price TargetBuy$10.00N/AView Rating Details
3/14/2016Credit Suisse GroupReiterated RatingNeutral$9.00N/AView Rating Details
11/22/2015William BlairReiterated RatingHold$10.00N/AView Rating Details
9/29/2015SunTrust Banks, Inc.DowngradeBuy -> NeutralN/AView Rating Details
8/24/2015Bank of America CorporationDowngradeUnderperformN/AView Rating Details
(Data available from 7/23/2015 forward)

Earnings

Earnings History for Vital Therapies (NASDAQ:VTL)
Earnings by Quarter for Vital Therapies (NASDAQ:VTL)
Earnings History by Quarter for Vital Therapies (NASDAQ VTL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/31/2017($0.35)N/AView Earnings Details
5/9/2017Q1 2017($0.37)($0.39)ViewListenView Earnings Details
3/7/2017Q4 2016($0.36)($0.37)ViewListenView Earnings Details
11/3/2016Q316($0.32)($0.32)ViewN/AView Earnings Details
8/2/2016Q216($0.33)($0.30)ViewN/AView Earnings Details
5/9/2016Q1($0.28)($0.31)ViewN/AView Earnings Details
3/8/2016Q415($0.42)($0.34)ViewN/AView Earnings Details
11/5/2015Q315($0.58)($0.51)ViewListenView Earnings Details
7/30/2015Q215($0.62)($0.63)ViewListenView Earnings Details
5/12/2015Q1($0.62)($0.62)ViewListenView Earnings Details
3/19/2015Q414($0.59)($0.59)ViewListenView Earnings Details
11/13/2014Q314($0.63)($0.59)ViewN/AView Earnings Details
8/6/2014Q214($0.04)($0.91)ViewN/AView Earnings Details
6/3/2014($0.54)($24.49)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Vital Therapies (NASDAQ:VTL)
Current Year EPS Consensus Estimate: $-1.76 EPS
Next Year EPS Consensus Estimate: $-1.31 EPS

Dividends

Dividend History for Vital Therapies (NASDAQ:VTL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Vital Therapies (NASDAQ:VTL)
Insider Ownership Percentage: 29.88%
Institutional Ownership Percentage: 26.62%
Insider Trades by Quarter for Vital Therapies (NASDAQ:VTL)
Institutional Ownership by Quarter for Vital Therapies (NASDAQ:VTL)
Insider Trades by Quarter for Vital Therapies (NASDAQ:VTL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2017John Michael DunnGeneral CounselBuy2,500$3.09$7,725.00View SEC Filing  
6/14/2017Muneer A SatterDirectorBuy20,000$3.07$61,400.00View SEC Filing  
6/14/2017Terence E WintersChairmanBuy10,000$3.10$31,000.00View SEC Filing  
6/13/2017Muneer A SatterDirectorBuy10,000$3.03$30,300.00View SEC Filing  
6/12/2017Muneer A SatterDirectorBuy30,000$3.11$93,300.00View SEC Filing  
6/9/2017Robert A AshleyInsiderBuy2,000$3.18$6,360.00View SEC Filing  
6/8/2017Duane NashPresidentBuy3,900$3.12$12,168.00View SEC Filing  
6/7/2017Muneer A SatterDirectorBuy20,000$3.20$64,000.00View SEC Filing  
6/6/2017Muneer A SatterDirectorBuy10,000$3.19$31,900.00View SEC Filing  
3/27/2017Muneer A SatterDirectorBuy3,750,000$4.00$15,000,000.00View SEC Filing  
8/12/2016Faheem HasnainDirectorBuy118,243$5.92$699,998.56View SEC Filing  
10/28/2015Muneer A SatterDirectorBuy400,000$5.50$2,200,000.00View SEC Filing  
10/26/2015Cheryl CohenDirectorBuy3,500$7.17$25,095.00View SEC Filing  
10/26/2015John Michael DunnGeneral CounselBuy9,385$6.81$63,911.85View SEC Filing  
9/10/2015Jean Jacques BienaimeDirectorBuy14,000$3.08$43,120.00View SEC Filing  
10/10/2014Terence E WintersCEOBuy1,360$14.86$20,209.60View SEC Filing  
10/8/2014Duane NashInsiderBuy100$17.50$1,750.00View SEC Filing  
10/8/2014Lowell SearsDirectorBuy1,429$17.50$25,007.50View SEC Filing  
6/3/2014Muneer A SatterDirectorBuy14,500$13.16$190,820.00View SEC Filing  
4/23/2014Muneer A SatterDirectorBuy360,966$12.00$4,331,592.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Vital Therapies (NASDAQ:VTL)
Latest Headlines for Vital Therapies (NASDAQ:VTL)
Source:
DateHeadline
americanbankingnews.com logoVital Therapies, Inc. (VTL) Expected to Post Earnings of -$0.30 Per Share
www.americanbankingnews.com - July 13 at 12:22 AM
americanbankingnews.com logo Analysts Expect Vital Therapies, Inc. (VTL) Will Post Earnings of -$0.31 Per Share
www.americanbankingnews.com - June 17 at 12:10 AM
americanbankingnews.com logoTerence E. Winters Buys 10,000 Shares of Vital Therapies, Inc. (VTL) Stock
www.americanbankingnews.com - June 15 at 8:06 PM
americanbankingnews.com logoVital Therapies, Inc. (VTL) Director Buys $30,300.00 in Stock
www.americanbankingnews.com - June 14 at 10:48 PM
americanbankingnews.com logoVital Therapies, Inc. (VTL) Director Purchases $61,400.00 in Stock
www.americanbankingnews.com - June 14 at 8:19 PM
americanbankingnews.com logoVital Therapies, Inc. (VTL) Director Acquires $93,300.00 in Stock
www.americanbankingnews.com - June 12 at 7:35 PM
americanbankingnews.com logoVital Therapies Inc (VTL) President Duane Nash Acquires 3,900 Shares
www.americanbankingnews.com - June 9 at 8:44 PM
americanbankingnews.com logoVital Therapies Inc (VTL) Director Purchases $31,900.00 in Stock
www.americanbankingnews.com - June 7 at 11:16 PM
americanbankingnews.com logoVital Therapies Inc (VTL) Director Muneer A. Satter Acquires 20,000 Shares
www.americanbankingnews.com - June 7 at 11:16 PM
finance.yahoo.com logoVital Therapies Announces Characteristics of Early Subjects in VTL-308 Pivotal Study of ELAD System in Severe Alcoholic Hepatitis
finance.yahoo.com - June 5 at 10:38 AM
americanbankingnews.com logoVital Therapies Inc (VTL) Downgraded to Strong Sell at ValuEngine
www.americanbankingnews.com - June 2 at 8:04 PM
americanbankingnews.com logoVital Therapies Inc (VTL) Now Covered by Raymond James Financial, Inc.
www.americanbankingnews.com - May 18 at 10:56 PM
finance.yahoo.com logoEdited Transcript of VTL earnings conference call or presentation 10-May-17 8:30pm GMT
finance.yahoo.com - May 12 at 4:18 AM
finance.yahoo.com logoInvestor Network: VITAL THERAPIES INC to Host Earnings Call
finance.yahoo.com - May 11 at 3:19 AM
americanbankingnews.com logoVital Therapies Inc (VTL) Upgraded at Zacks Investment Research
www.americanbankingnews.com - May 10 at 10:36 PM
americanbankingnews.com logoVital Therapies Inc (VTL) Announces Quarterly Earnings Results
www.americanbankingnews.com - May 9 at 9:42 PM
finance.yahoo.com logoVital Therapies Announces First Quarter 2017 Financial Results
finance.yahoo.com - May 9 at 8:05 PM
marketbeat.com logoVital Therapies reports 1Q loss
marketbeat.com - May 9 at 7:28 PM
americanbankingnews.com logoVital Therapies Inc (VTL) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - May 7 at 7:28 AM
americanbankingnews.com logoFavorable Press Coverage Likely to Impact Vital Therapies (VTL) Stock Price
www.americanbankingnews.com - May 3 at 8:08 PM
americanbankingnews.com logoSomewhat Critical Media Coverage Extremely Likely to Affect Vital Therapies (VTL) Stock Price
www.americanbankingnews.com - April 30 at 8:58 AM
americanbankingnews.com logo-$0.37 Earnings Per Share Expected for Vital Therapies Inc (VTL) This Quarter
www.americanbankingnews.com - April 29 at 1:14 AM
americanbankingnews.com logoSomewhat Favorable Media Coverage Unlikely to Impact Vital Therapies (VTL) Stock Price
www.americanbankingnews.com - April 27 at 11:56 AM
americanbankingnews.com logoVital Therapies (VTL) Getting Positive Media Coverage, Study Shows
www.americanbankingnews.com - April 21 at 6:02 PM
americanbankingnews.com logoVital Therapies Inc (VTL) Short Interest Down 9.2% in March
www.americanbankingnews.com - April 15 at 5:56 PM
americanbankingnews.com logoSomewhat Positive Media Coverage Extremely Likely to Impact Vital Therapies (VTL) Share Price
www.americanbankingnews.com - April 15 at 8:02 AM
americanbankingnews.com logoVital Therapies Inc (VTL) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - April 14 at 9:30 AM
americanbankingnews.com logoVital Therapies Inc (VTL) Expected to Post Earnings of -$0.37 Per Share
www.americanbankingnews.com - April 7 at 8:03 PM
americanbankingnews.com logoVital Therapies Inc (VTL) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 6 at 1:43 PM
americanbankingnews.com logoMuneer A. Satter Purchases 3,750,000 Shares of Vital Therapies Inc (VTL) Stock
www.americanbankingnews.com - March 27 at 10:25 PM
americanbankingnews.com logoVital Therapies Inc (VTL) Downgraded by Zacks Investment Research to Sell
www.americanbankingnews.com - March 25 at 7:23 AM
biz.yahoo.com logoVITAL THERAPIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement
biz.yahoo.com - March 23 at 8:57 PM
finance.yahoo.com logo9:08 am Vital Therapies prices an underwritten public offering of 8.75 mln shares of common stock at $4.00/share for gross proceeds of about $35.0 mln
finance.yahoo.com - March 23 at 7:27 AM
biz.yahoo.com logoVITAL THERAPIES INC Files SEC form 8-K, Other Events
biz.yahoo.com - March 21 at 8:21 PM
finance.yahoo.com logoEdited Transcript of VTL earnings conference call or presentation 7-Mar-17 9:30pm GMT
finance.yahoo.com - March 9 at 4:30 AM
us.rd.yahoo.com logoVital Therapies Announces Fourth Quarter and Full Year 2016 Financial Results
us.rd.yahoo.com - March 8 at 12:24 AM
us.rd.yahoo.com logo4:02 pm Vital Therapies misses by $0.01
us.rd.yahoo.com - March 8 at 12:24 AM
biz.yahoo.com logoQ4 2016 Vital Therapies Inc Earnings Release - After Market Close
biz.yahoo.com - March 7 at 8:19 AM
finance.yahoo.com logoVital Therapies Announces Upcoming Fourth Quarter and Full Year 2016 Financial Results Conference Call With Webcast
finance.yahoo.com - February 27 at 5:24 PM
finance.yahoo.com logoEdited Transcript of VTL earnings conference call or presentation 3-Nov-16 8:30pm GMT
finance.yahoo.com - November 7 at 12:38 PM
biz.yahoo.com logoQ3 2016 Vital Therapies Inc Earnings Release - After Market Close
biz.yahoo.com - November 3 at 12:39 PM
streetinsider.com logoVital Therapies (VTL) Offers Corporate Update; Says 14 Subjects Enrolled in VTL-308
www.streetinsider.com - September 15 at 8:09 PM
biz.yahoo.com logoVITAL THERAPIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - August 29 at 8:05 PM
biz.yahoo.com logoVITAL THERAPIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
biz.yahoo.com - August 15 at 10:14 AM
finance.yahoo.com logoEdited Transcript of VTL earnings conference call or presentation 2-Aug-16 8:30pm GMT
finance.yahoo.com - August 3 at 11:33 AM
nasdaq.com logoVital Therapies Announces Second Quarter Financial Results
www.nasdaq.com - August 2 at 8:37 PM
biz.yahoo.com logoQ2 2016 Vital Therapies Inc Earnings Release - After Market Close
biz.yahoo.com - August 2 at 7:22 AM
finance.yahoo.com logoVital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With Webcast
finance.yahoo.com - July 21 at 4:01 PM
finance.yahoo.com logoLooking for a Growth Stock? Why It is Time to Focus on Vital Therapies (VTL)
finance.yahoo.com - June 14 at 9:44 AM
biz.yahoo.com logoVITAL THERAPIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of
biz.yahoo.com - May 27 at 4:33 PM

Social

Chart

Vital Therapies (VTL) Chart for Sunday, July, 23, 2017

This page was last updated on 7/23/2017 by MarketBeat.com Staff